Your browser doesn't support javascript.
loading
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons.
Forero, Adriana; Ozarkar, Snehal; Li, Hongchuan; Lee, Chia Heng; Hemann, Emily A; Nadjsombati, Marija S; Hendricks, Matthew R; So, Lomon; Green, Richard; Roy, Chandra N; Sarkar, Saumendra N; von Moltke, Jakob; Anderson, Stephen K; Gale, Michael; Savan, Ram.
Afiliación
  • Forero A; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Ozarkar S; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Li H; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Lee CH; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Hemann EA; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Nadjsombati MS; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Hendricks MR; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • So L; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Green R; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.
  • Roy CN; University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
  • Sarkar SN; University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
  • von Moltke J; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Anderson SK; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
  • Gale M; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.
  • Savan R; Department of Immunology, School of Medicine, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA. Electronic address: savanram@uw.edu.
Immunity ; 51(3): 451-464.e6, 2019 09 17.
Article en En | MEDLINE | ID: mdl-31471108
ABSTRACT
Type I and III interferons (IFNs) activate similar downstream signaling cascades, but unlike type I IFNs, type III IFNs (IFNλ) do not elicit strong inflammatory responses in vivo. Here, we examined the molecular mechanisms underlying this disparity. Type I and III IFNs displayed kinetic differences in expression of IFN-stimulated genes and proinflammatory responses, with type I IFNs preferentially stimulating expression of the transcription factor IRF1. Type III IFNs failed to induce IRF1 expression because of low IFNλ receptor abundance and insufficient STAT1 activation on epithelial cells and thus did not activate the IRF1 proinflammatory gene program. Rather, IFNλ stimulation preferentially induced factors implicated in tissue repair. Our findings suggest that IFN receptor compartmentalization and abundance confer a spatiotemporal division of labor where type III IFNs control viral spread at the site of the infection while restricting tissue damage; the transient induction of inflammatory responses by type I IFNs recruits immune effectors to promote protective immunity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Interferones / Factor 1 Regulador del Interferón Límite: Animals / Humans / Male Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Interferones / Factor 1 Regulador del Interferón Límite: Animals / Humans / Male Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos